TREATMENT OF ACUTE VIRAL HEPATITIS WITH (+)-CYANIDANOL-3
β Scribed by BLUM, A
- Book ID
- 122010288
- Publisher
- The Lancet
- Year
- 1977
- Tongue
- English
- Weight
- 372 KB
- Volume
- 310
- Category
- Article
- ISSN
- 0140-6736
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
One-hundred sixty patients (81 cyanidanol, 79 placebo) were included in a double-blind placebo-controlled clinical trial to evaluate the effect of 3 gm (+)-cyanidanol-3 per day for 8 weeks on the clinical course of acute viral hepatitis and HBsAg elimination. Quantitative determination of HBsAg was
A double-blind trial was carried out on 124 randomized patients with acute viral hepatitis, of whom 58 were treated with (+)-cyanidanol-3 in a dose of 3 g m per day and 66 with placebo. The treatment was given for 50 days. At 5-day intervals, SGPT, SGOT, and total serum bilirubin levels were tested.